EMZOLAM

Main information

  • Trade name:
  • EMZOLAM 5 CAP
  • Dosage:
  • 20MG
  • Pharmaceutical form:
  • CAP
  • Composition:
  • 5
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMZOLAM 5 CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

10-7-2018

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4481 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Temozolomide Sandoz (Sandoz GmbH)

Temozolomide Sandoz (Sandoz GmbH)

Temozolomide Sandoz (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018)4480 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

3-7-2018

Temozolomide Accord (Accord Healthcare Limited)

Temozolomide Accord (Accord Healthcare Limited)

Temozolomide Accord (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4240 of Tue, 03 Jul 2018

Europe -DG Health and Food Safety

30-5-2018

Temodal (Merck Sharp and Dohme Limited)

Temodal (Merck Sharp and Dohme Limited)

Temodal (Active substance: temozolomide) - PSUSA - Modification - Commission Decision (2018)3466 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/229/PSUSA/2886/201707

Europe -DG Health and Food Safety